HealthDay News — Roughly one in five (21 percent) of idiopathic pulmonary fibrosis (IPF) deaths might be related to occupational exposures, according to research published in the March 6 issue of the ...

Idiopathic pulmonary fibrosis is a life-threatening lung disease AdAlta’s lead candidate AD-214 is a first-in-class molecule ...

According to a recent study, roughly one in five of idiopathic pulmonary fibrosis deaths might be related to occupational exposures.

The Government's recently launched AI Action Plan, focusing on creating a National Data Library, marks a pivotal moment for the use of AI in healthcare. It has the potential to unlock unprecedented ...

Only a handful of the non-COPD online PR videos reviewed targeted specific lung diseases, including IPF (10%; n=6) and COVID-19 sequelae (5%; n=3). Online pulmonary rehabilitation (PR) videos were ...

Qureight and Remedy Cell have collaborated to validate the mechanism of action of RC-0315 in the Phase Ib clinical trial for treating idiopathic pulmonary fibrosis (IPF). The trial’s primary objective ...